Latest Articles
GSK gets expanded EU approval for Jemperli in endometrial cancer - MSN
GSK gets expanded EU approval for Jemperli in endometrial cancer MSN
Published: Jan. 21, 2025, 7:31 p.m.
Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer - Yahoo Finance
Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer Yahoo Finance
Published: Jan. 21, 2025, 6:43 p.m.
GSK's Jemperli Gets EU Nod for Expanded Use in Endometrial Cancer - Yahoo Finance
GSK's Jemperli Gets EU Nod for Expanded Use in Endometrial Cancer Yahoo Finance
Published: Jan. 21, 2025, 2:35 p.m.
EU approves endometrial, lung cancer drugs from GSK and J&J - pharmaphorum
EU approves endometrial, lung cancer drugs from GSK and J&J pharmaphorum
Published: Jan. 21, 2025, 1:59 p.m.
GSK’s Jemperli Gains Expanded EU Approval for Endometrial Cancer - TipRanks
GSK’s Jemperli Gains Expanded EU Approval for Endometrial Cancer TipRanks
Published: Jan. 21, 2025, 12:20 p.m.
Does Chemoradiotherapy Boost Survival in Endometrial Cancer? - Medscape
Does Chemoradiotherapy Boost Survival in Endometrial Cancer? Medscape
Published: Jan. 21, 2025, 9:45 a.m.
EC approves GSK’s Jemperli-chemo combo for endometrial cancer - Pharmaceutical Technology
EC approves GSK’s Jemperli-chemo combo for endometrial cancer Pharmaceutical Technology
Published: Jan. 21, 2025, 9:35 a.m.
GSK gets European Commission nod for expanded use of Jemperli in endometrial cancer - Medical Dialogues
GSK gets European Commission nod for expanded use of Jemperli in endometrial cancer Medical Dialogues
Published: Jan. 21, 2025, 8 a.m.
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer - Indian Pharma Post
European Commission expands Jemperli plus chemotherapy approval for endometrial cancer Indian Pharma Post
Published: Jan. 21, 2025, 4:36 a.m.
Neutrophils initiate pro-inflammatory immune responses in early endometriosis lesion development.
Endometriosis is a chronic gynecological disease that affects 1 in 10 reproductive-aged women. Most studies investigate established disease; however, the initiation and early events in endometriotic lesion development remain poorly …
Published: Jan. 21, 2025, midnight
Link copied to clipboard!